Ocular GAGs, Lysosomal Storage Diseases, Eicosanoids, and Thyroid Endocrinology

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/28

flashcard set

Earn XP

Description and Tags

Comprehensive vocabulary flashcards covering ocular glycosaminoglycans, lysosomal storage diseases, eicosanoid biochemistry, thyroid hormone synthesis, and Graves' disease pathophysiology.

29 Terms

1
New cards

Glycosaminoglycans (GAGs)

Long, unbranched polymers of repeating disaccharide units (composed of an amino sugar and an acidic or second sugar) carrying negatively charged carboxylate and sulfate groups that attract cations and hold water.

2
New cards

Viscoelasticity

The mechanical property of a substance—such as hyaluronate in the vitreous—that enables it to deform under applied force and recover its original shape and volume.

3
New cards

Hyaluronate

An enormous, non-sulfated ocular glycosaminoglycan consisting of repeating glucuronic acid and N-acetylglucosamine units that exists as an unattached, free chain in the vitreous.

4
New cards

Decorin

A small corneal proteoglycan whose core protein binds type I collagen fibrils and carries a single chondroitin or dermatan sulfate chain that acts as a molecular spacer.

5
New cards

Lumican

A corneal proteoglycan that binds to type I collagen and bears keratan sulfate glycosaminoglycan chains to maintain stromal fibril spacing.

6
New cards

Keratocan

A corneal proteoglycan that attaches keratan sulfate chains and functions alongside other small leucine-rich proteoglycans to maintain corneal transparency.

7
New cards

Mimecan

A corneal proteoglycan that carries keratan sulfate chains and contributes to the uniform organization and spacing of collagen fibrils in the stroma.

8
New cards

Mucopolysaccharidoses (MPS)

A group of lysosomal storage diseases caused by inherited deficiencies of specific lysosomal enzymes responsible for breaking down glycosaminoglycans, leading to cellular engorgement and organ damage.

9
New cards

Hurler Syndrome (MPS I)

A severe autosomal recessive lysosomal storage disease caused by a deficiency of α-L-iduronidase\alpha\text{-L-iduronidase}, causing excessive storage of dermatan sulfate and heparan sulfate, severe corneal clouding, skeletal stiffness, and optic nerve damage.

10
New cards

Hunter Syndrome (MPS II)

An X-linked recessive mucopolysaccharidosis caused by a deficiency of iduronate-2-sulfatase, resulting in dermatan sulfate and heparan sulfate accumulation, mild or uncommon corneal clouding, and optic disc swelling or atrophy.

11
New cards

Sanfilippo Syndrome (MPS III)

An autosomal recessive lysosomal storage disease resulting from a defect in one of four heparan sulfate-degrading enzymes, marked by severe pigmentary retinal degeneration, mild optic nerve involvement, and usually insignificant corneal clouding.

12
New cards

Morquio Syndrome (MPS IV)

An autosomal recessive mucopolysaccharidosis caused by a deficiency of N-acetylgalactosamine-6-sulfatase (Type A) or β-galactosidase\beta\text{-galactosidase} (Type B), characterized by keratan sulfate accumulation and mild to variable corneal clouding.

13
New cards

Maroteaux–Lamy Syndrome (MPS VI)

An autosomal recessive condition caused by a deficiency of N-acetylgalactosamine-4-sulfatase (arylsulfatase B), resulting in dermatan sulfate accumulation, severe corneal clouding, and moderate optic nerve damage without typical retinal degeneration.

14
New cards

Sly Syndrome (MPS VII)

An autosomal recessive lysosomal storage disease caused by a deficiency of β-glucuronidase\beta\text{-glucuronidase}, which leads to dermatan sulfate and heparan sulfate accumulation with variable corneal clouding.

15
New cards

Tay-Sachs Disease

An infantile-onset storage disorder caused by a deficiency of β-hexosaminidase A\beta\text{-hexosaminidase A} (HEXA gene), resulting in the toxic accumulation of GM2GM_2 ganglioside in neurons and the retina, clinically presenting with a macular cherry-red spot.

16
New cards

I-Cell Disease

A lysosomal trafficking disorder caused by a defect in GlcNAc-1-phosphotransferase, which prevents the addition of mannose-6-phosphate (M6P) tags and causes lysosomal enzymes to be secreted extracellularly rather than routed into lysosomes.

17
New cards

Eicosanoids

Locally acting signaling molecules produced by the oxidation of 20-carbon polyunsaturated fatty acids (such as arachidonic acid) that mediate inflammation, smooth muscle tone, and immunity.

18
New cards

Phospholipase A2A_2

A membrane enzyme that hydrolyzes membrane phospholipids to release arachidonic acid upon activation by G-protein-coupled receptors or mechanical injury; its activity is inhibited by corticosteroids.

19
New cards

Prostaglandin H Synthase

A membrane-associated bifunctional enzyme with cyclooxygenase (COX) and peroxidase activities that converts free arachidonic acid into PGH2\text{PGH}_2; it is inhibited by aspirin and NSAIDs.

20
New cards

12(R)-HETE12(R)\text{-HETE}

An eicosanoid synthesized by cytochrome P450 in the corneal epithelium that inhibits Na+/K+-ATPase\text{Na}^+/\text{K}^+\text{-ATPase} in the corneal endothelium, contributing to corneal stromal swelling and inflammation.

21
New cards

PGF2α\text{PGF}_{2\alpha}

A prostaglandin derivative that relaxes the ciliary muscle to promote uveoscleral outflow and lower intraocular pressure, providing the basis for topical prostaglandin-analog glaucoma medications.

22
New cards

Sodium-Iodide Symporter (NIS)

A transporter located on the basal membrane of thyroid follicular cells that drives the rate-limiting trapping of iodide, concentrating it 30–40-fold against its gradient using the sodium concentration gradient.

23
New cards

Thyroglobulin

A large, tyrosine-rich glycoprotein synthesized in thyroid follicular cells and secreted into the lumen colloid to serve as the protein scaffold for thyroid hormone synthesis and storage.

24
New cards

Thyroid Peroxidase (TPO)

An enzyme that uses H2O2\text{H}_2\text{O}_2 to oxidize iodide, attach it to tyrosyl residues in thyroglobulin (iodine organification), and couple MIT and DIT into T3T_3 and T4T_4.

25
New cards

Graves' Disease

The most common autoimmune cause of hyperthyroidism, mediated by autoantibodies against the TSH receptor that continuously stimulate thyroid hormone production and enlargement without destroying the gland.

26
New cards

Thyroid-Stimulating Immunoglobulin (TSI)

An activating autoantibody in Graves' disease that binds the TSH receptor on thyroid follicular cells and orbital fibroblasts, exerting an effect that is slower and longer lasting than endogenous TSH.

27
New cards

Thyroid Eye Disease (TED)

An autoimmune orbital disorder characterized by proptosis, eyelid retraction, and diplopia driven by TSI stimulation of orbital fibroblasts and preadipocytes, triggering hyaluronan synthesis, adipogenesis, and fluid retention.

28
New cards

Pretibial Myxedema

A clinical manifestation of Graves' disease characterized by a lumpy, reddish-orange thickening of the skin over the anterior shins, caused by local accumulation of glycosaminoglycans.

29
New cards

Zinc Finger

A structural protein motif within the DNA-binding domain of the intracellular nuclear receptor superfamily in which a zinc ion is coordinated by two cysteine and two histidine residues to bind target DNA sequences.